Resistance to antiretroviral therapy among patients in Uganda
Article Abstract:
Doctors can use the same methods to monitor the occurrence of drug resistant strains of HIV in countries where the strain of virus is different than in the US. Ninety percent of the patients who took lamivudine became resistant to the drug.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
Article Abstract:
Over half of 68 HIV patients in Cote d'Ivoire who were taking AIDS drugs became resistant to one or more of the drugs. Forty percent became resistant to nucleoside reverse transcriptase inhibitors, 8% became resistant to non-nucleoside reverse transcriptase inhibitors, and 6% became resistant to protease inhibitors.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda
Article Abstract:
The long-term experience of providing anti-retroviral (ARV) therapy, including CD4 (super +) cell count and virologic response, at St. Francis Hospital, Nsambya, Uganda is described. The results of the evaluation of this fee-for-service model highlight the constraints of keeping patients in care and the high mortality among patients accessing ARV therapy at an advanced stage of HIV disease.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy
- Abstracts: Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
- Abstracts: Incidence of adverse drug events and potential adverse drug events: implications for prevention. Medication Errors and Adverse Drug Events in Pediatric Inpatients
- Abstracts: Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence
- Abstracts: Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy